Physician profile
Michael Z Arbel
NPI 1417997321
$465.57
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.80 · 2020: $18.30 · 2021: $79.04 · 2022: $89.56 · 2023: $133 · 2024: $78.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $210.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $128.95 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $76.91 | 2019-2024 | M-M-R II, Gardasil 9, Vaxelis |
| Sanofi Pasteur INC. | $76.60 | 2019-2023 | |
| Cranial Technologies, INC | $61.62 | 2022-2024 | Doc Band |
| Glaxosmithkline, LLC. | $49.35 | 2019-2021 | |
| Ultragenyx Pharmaceutical INC. | $21.14 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $18.73 | 2023 | Flumist Quadrivalent |
| Alexion Pharmaceuticals, INC. | $17.00 | 2019 | |
| Sobi, INC | $15.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Arbel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.